Dickenson AH. Where and how do opioids act? In Gebhart GF, Hammond DL, Jensen TS eds. Proceedings of the 7th World Congress on Pain, Progress in Pain Research and Management, Vol 2. Seattle, WA: IASP Press, 1994: 525–552.
3.
Chapman V, Dickenson AH. The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn. Brain Res1992; 573: 321–323.
4.
Yamamoto T, Yaksh TL. Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy. Neurosci Lett1992; 135: 67–70.
5.
Elliott K, Minami N, Kolesnikov YA, Pasternak, GW, Inturrisi CE. NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain1994; 56: 69–75.
6.
Budd K. Monoamine function and analgesia. Pain Revs1994;1: 3–8.
7.
Bartlet SE, Dodd PR, Smith MT. Pharmacology of morphine and morphine-3-glucuronide at opioid, excitatory amino acid, GABA and glycine binding sites. Pharmacol Toxicol1994; 75: 73–81.
8.
Ebert B, Andersen S, Krogsgaard-Larsen P. Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci Lett1995; 187: 165–168.
9.
Gorman AL, Elliott KJ, Inturrisi CE. The d- and lisomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci Lett1997; 223: 5–8.
10.
Codd EE, Shank RP, Schupsky JJ, Raffa RB. Serotonin and norepinephrine inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. J Pharmacol Exp Therap1995; 274: 1263–1270.
11.
Magnan J, Paterson SJ, Tavani A, Kosterlitz HW. The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties. Naunyn-Schmiedeberg's Pharmacol1982; 319: 197–205.
12.
Ivarsson M, Neil A. Differences in efficacies between morphine and methadone demonstrated in guinea pig ileum: a possible explanation for previous observations on incomplete opioid cross-tolerance. Pharmacol Toxicol1989; 65: 368–371.
13.
Morley JS, Makin MK. The use of methadone in cancer pain poorly responsive to other opioids. Pain Reviews1998; 5: 51–58.
14.
Makin MK, O'Donnell V, Skinner JM, Ellershaw JE. Methadone in the management of cancer related neuropathic pain. Pain Clinic1998, 10: 275–279.
